The pattern and outcome of acute severe colitis
…, MN Protic, G Heap, F Cummings… - Journal of Crohn's …, 2010 - academic.oup.com
Background: The prognosis of acute severe ulcerative colitis (ASC) influences therapeutic
decisions, but data on prevalence or long-term outcome are few. Methods: A systematic …
decisions, but data on prevalence or long-term outcome are few. Methods: A systematic …
Comparison of quantum and semiclassical radiation theories with application to the beam maser
ET Jaynes, FW Cummings - Proceedings of the IEEE, 1963 - ieeexplore.ieee.org
… For any motion in which either of the points W= f (hQ/2) is accessible, we have the constant
… , we have to solve the system of linear equaand this F(t) causes a change of E1 in the electric …
… , we have to solve the system of linear equaand this F(t) causes a change of E1 in the electric …
Stimulated emission of radiation in a single mode
FW Cummings - Physical Review, 1965 - APS
Recently Glauber has described the properties of coherent radiation fields, and has constructed
the density matrix of the field in two simple cases:(1) The radiating system is a classical …
the density matrix of the field in two simple cases:(1) The radiating system is a classical …
Relapse after withdrawal from anti‐TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta‐analysis
…, C Christodoulou, F Cummings… - Alimentary …, 2016 - Wiley Online Library
Background Infliximab and adalimumab have established roles in inflammatory bowel disease
( IBD ) therapy. UK regulators mandate reassessment after 12 months' anti‐ TNF therapy …
( IBD ) therapy. UK regulators mandate reassessment after 12 months' anti‐ TNF therapy …
Exact Solution for an -Molecule—Radiation-Field Hamiltonian
M Tavis, FW Cummings - Physical Review, 1968 - APS
The exact solution for a problem of N identical two-level molecules interacting through a dipole
coupling with a single-mode quantized radiation field at resonance is given. Approximate …
coupling with a single-mode quantized radiation field at resonance is given. Approximate …
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility
…, SA Fisher, RG Roberts, ER Nimmo, FR Cummings… - Nature …, 2007 - nature.com
A genome-wide association scan in individuals with Crohn's disease by the Wellcome Trust
Case Control Consortium detected strong association at four novel loci. We tested 37 SNPs …
Case Control Consortium detected strong association at four novel loci. We tested 37 SNPs …
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease
We report results of a nonsynonymous SNP scan for ulcerative colitis and identify a previously
unknown susceptibility locus at ECM1. We also show that several risk loci are common to …
unknown susceptibility locus at ECM1. We also show that several risk loci are common to …
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative …
…, BL Fowble, LJ Solin, FJ Cummings… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: To assess patterns of failure and how selected prognostic and treatment factors
affect the risks of locoregional failure (LRF) after mastectomy in breast cancer patients with …
affect the risks of locoregional failure (LRF) after mastectomy in breast cancer patients with …
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre …
…, JH Cheon, H Cichoz-Lach, L Clark, F Cummings… - The Lancet, 2022 - thelancet.com
Background Active-comparator trials are important to inform patient and physician choice.
We aimed to evaluate the efficacy and safety of monotherapy with either ustekinumab or …
We aimed to evaluate the efficacy and safety of monotherapy with either ustekinumab or …
[HTML][HTML] HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn's disease
… JR Fraser Cummings reports personal fees from AbbVie, grants and personal fees from
Biogen, personal fees from MSD, Celltrion, NAPP, and Sandoz. Peter M. Irving reports personal …
Biogen, personal fees from MSD, Celltrion, NAPP, and Sandoz. Peter M. Irving reports personal …